These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36481106)

  • 1. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
    Prosperi C; Thangaraj JWV; Hasan AZ; Kumar MS; Truelove S; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Cutts FT; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murhekar MV
    Vaccine; 2023 Jan; 41(2):486-495. PubMed ID: 36481106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges Addressing Inequalities in Measles Vaccine Coverage in Zambia through a Measles-Rubella Supplementary Immunization Activity during the COVID-19 Pandemic.
    Yang Y; Kostandova N; Mwansa FD; Nakazwe C; Namukoko H; Sakala C; Bobo P; Masumbu PK; Nachinga B; Ngula D; Carcelen AC; Prosperi C; Winter AK; Moss WJ; Mutembo S
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020.
    Thangaraj JWV; Prosperi C; Kumar MS; Hasan AZ; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sarmah NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murherkar MV
    PLoS One; 2024; 19(3):e0297385. PubMed ID: 38551928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the effect of measles and rubella mass vaccination campaigns on seroprevalence in India: a before-and-after cross-sectional household serosurvey in four districts, 2018-2020.
    Murhekar MV; Gupta N; Hasan AZ; Kumar MS; Kumar VS; Prosperi C; Sapkal GN; Thangaraj JWV; Kaduskar O; Bhatt V; Deshpande GR; Thankappan UP; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma S; Sarmah NP; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Shrivastava AK; Chonker SK; Tilekar B; Tandale BV; Ahmad M; Sangal L; Winter A; Mehendale SM; Moss WJ; Hayford K
    Lancet Glob Health; 2022 Nov; 10(11):e1655-e1664. PubMed ID: 36240831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
    Tohme RA; François J; Wannemuehler K; Magloire R; Danovaro-Holliday MC; Flannery B; Cavallaro KF; Fitter DL; Purcell N; Dismer A; Tappero JW; Vertefeuille JF; Hyde TB
    Trop Med Int Health; 2014 Sep; 19(9):1105-15. PubMed ID: 25041586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
    Portnoy A; Jit M; Helleringer S; Verguet S
    Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the Cost of Vaccinating a Measles Zero-Dose Child in Zambia Using Three Vaccination Strategies.
    Mak J; Patenaude BN; Mutembo S; Pilewskie ME; Winter AK; Moss WJ; Carcelen AC
    Am J Trop Med Hyg; 2024 Jul; 111(1):121-128. PubMed ID: 38772386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proportion of children aged 9-59 months reached by the 2017 measles supplementary immunization activity among the children with or without history of measles vaccination in Lilongwe district, Malawi.
    Kainga HW; Ssendagire S; Ssanyu JN; Nabukeera S; Namuhani N; Mangen FW
    PLoS One; 2021; 16(1):e0243137. PubMed ID: 33428640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who gets vaccinated in a measles-rubella campaign in Nepal?: results from a post-campaign coverage survey.
    Danovaro-Holliday MC; Rhoda DA; Lacoul M; Prier ML; Gautam JS; Pokhrel TN; Dixit SM; Rajbhandari RM; Bose AS
    BMC Public Health; 2022 Feb; 22(1):221. PubMed ID: 35114969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study.
    Auzenbergs M; Fu H; Abbas K; Procter SR; Cutts FT; Jit M
    Lancet Glob Health; 2023 Aug; 11(8):e1194-e1204. PubMed ID: 37474227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A; Vincent A; Selvaraj K; Manikandan M
    Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal.
    Wallace AS; Bohara R; Stewart S; Subedi G; Anand A; Burnett E; Giri J; Shrestha J; Gurau S; Dixit S; Rajbhandari R; Schluter WW
    J Infect Dis; 2017 Jul; 216(suppl_1):S280-S286. PubMed ID: 28838201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ; Orenstein WA
    Vaccine; 2018 Sep; 36(37):5645-5650. PubMed ID: 30041881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002.
    Vijayaraghavan M; Martin RM; Sangrujee N; Kimani GN; Oyombe S; Kalu A; Runyago A; Wanjau G; Cairns L; Muchiri SN
    Health Policy; 2007 Sep; 83(1):27-36. PubMed ID: 17174435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S; Tabu C; N'ganga J; Awes AA; Sergon K; Cosmas L; Styczynski A; Thuo S; Lebo E; Kaiser R; Perry R; Ademba P; Kretsinger K; Onuekwusi I; Gary H; Scobie HM
    PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
    Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K
    PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles-Rubella Supplementary Immunization Activity Readiness Assessment - India, 2017-2018.
    Gurnani V; Haldar P; Khanal S; Bhatnagar P; Singh B; Ahmed D; Samiuddin M; Kumar A; Negi Y; Gupta S; Harvey P; Bahl S; Dabbagh A; Alexander JP; Goodson JL
    MMWR Morb Mortal Wkly Rep; 2018 Jul; 67(26):742-746. PubMed ID: 29975677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling measles using supplemental immunization activities: a mathematical model to inform optimal policy.
    Verguet S; Johri M; Morris SK; Gauvreau CL; Jha P; Jit M
    Vaccine; 2015 Mar; 33(10):1291-6. PubMed ID: 25541214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress Toward Measles and Rubella Elimination - India, 2005-2021.
    Murugan R; VanderEnde K; Dhawan V; Haldar P; Chatterjee S; Sharma D; Dzeyie KA; Pattabhiramaiah SB; Khanal S; Sangal L; Bahl S; Tanwar SSS; Morales M; Kassem AM
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(50):1569-1575. PubMed ID: 36520657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.